Ensysce Biosciences (ENSC) Notes Payables (2020 - 2025)
Historic Notes Payables for Ensysce Biosciences (ENSC) over the last 6 years, with Q3 2025 value amounting to $387702.0.
- Ensysce Biosciences' Notes Payables rose 13.59% to $387702.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $387702.0, marking a year-over-year increase of 13.59%. This contributed to the annual value of $301660.0 for FY2024, which is 6470.56% down from last year.
- As of Q3 2025, Ensysce Biosciences' Notes Payables stood at $387702.0, which was up 13.59% from $424521.0 recorded in Q2 2025.
- Over the past 5 years, Ensysce Biosciences' Notes Payables peaked at $17.2 million during Q4 2021, and registered a low of $257383.0 during Q1 2025.
- Moreover, its 5-year median value for Notes Payables was $466055.0 (2021), whereas its average is $3.7 million.
- In the last 5 years, Ensysce Biosciences' Notes Payables soared by 161653.56% in 2022 and then crashed by 9607.45% in 2023.
- Quarter analysis of 5 years shows Ensysce Biosciences' Notes Payables stood at $17.2 million in 2021, then tumbled by 74.36% to $4.4 million in 2022, then crashed by 80.6% to $854697.0 in 2023, then crashed by 64.71% to $301660.0 in 2024, then rose by 28.52% to $387702.0 in 2025.
- Its Notes Payables stands at $387702.0 for Q3 2025, versus $424521.0 for Q2 2025 and $257383.0 for Q1 2025.